Tweak

InsaneJournal

Tweak says, "Who's on first?"

Username: 
Password:    
Remember Me
  • Create Account
  • IJ Login
  • OpenID Login
Search by : 
  • View
    • Create Account
    • IJ Login
    • OpenID Login
  • Journal
    • Post
    • Edit Entries
    • Customize Journal
    • Comment Settings
    • Recent Comments
    • Manage Tags
  • Account
    • Manage Account
    • Viewing Options
    • Manage Profile
    • Manage Notifications
    • Manage Pictures
    • Manage Schools
    • Account Status
  • Friends
    • Edit Friends
    • Edit Custom Groups
    • Friends Filter
    • Nudge Friends
    • Invite
    • Create RSS Feed
  • Asylums
    • Post
    • Asylum Invitations
    • Manage Asylums
    • Create Asylum
  • Site
    • Support
    • Upgrade Account
    • FAQs
    • Search By Location
    • Search By Interest
    • Search Randomly

avanc99 ([info]avanc99) wrote,
@ 2011-12-06 18:35:00

Previous Entry  Add to memories!  Tell a Friend!  Next Entry
Current mood: scared

Drug infonet - deltason - [general]


Drug Infonet provides drug and disease information to your healthcare needs. Visit our FAQ page to seek out techniques to common health questions. Look around the Manufacturer Info page to url to pharmaceutical company pages. Click to Health Info and Health News to the latest in healthcare developments.

Drug Infonet brings this free resource for you so that you will be a more informed consumer of healthcare.

Deltasone
model of prednisone
tablets, USP


DESCRIPTION

ACTIONS

INDICATIONS

CONTRAINDICATIONS

WARNINGS

PRECAUTIONS

ADVERSE REACTIONS

DOSAGE AND ADMINISTRATION

HOW SUPPLIED

DESCRIPTION


DELTASONE Tablets contain prednisone that is a glucocorticoid. Glucocorticoids are adrenocortical
steroids, both natural and synthetic, that are readily absorbed from your gastrointestinal tract. Prednisone can be a white to practically white, odorless, crystalline powder. It is quite slightly soluble in water; slightly
soluble in alcohol, in chloroform, in dioxane, plus in methanol.

Caffeine reputation for prednisone is pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy- and its molecular weight
is 358. 43.

The structural formula is represented below:



DELTASONE Tablets are available in 5 strengths: 2. 5 mg, 5 mg, 10 mg, 20 mg and 50 mg. Inactive
ingredients: 2. 5 mg-Calcium Stearate, Corn Starch, Erythrosine Sodium, Lactose, Mineral Oil, Sorbic Acid and
Sucrose. 5 mg- Calcium Stearate, Corn Starch, Lactose, Mineral Oil, Sorbic Acid and Sucrose. 10 mg-Calcium
Stearate, Corn Starch, Lactose, Sorbic Acid and Sucrose. 20 mg-Calcium Stearate, Corn Starch, FD&C Yellow
No buy levitra online without prescription. 6, Lactose, Sorbic Acid and Sucrose. 50 mg-Corn Starch, Lactose, Magnesium Stearate, Sorbic Acid,
Sucrose, and Talc.


The surface of page


ACTIONS


Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties,
are employed as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used
for potent anti-inflammatory effects in disorders of countless organ systems.

Glucocorticoids cause profound and varied metabolic effects. In addition, they customize the body's immune
responses to diverse stimuli.


Top of page


INDICATIONS


DELTASONE Tablets are indicated in this conditions:

  • Endocrine Disorders

    Primary or secondary adrenocortical insufficiency
      (hydrocortisone or cortisone will be the first choice; synthetic
      analogs can be utilised in partnership with mineralocorticoids where applicable; in infancy mineralocorticoid
      supplementation is of particular importance)

    Congenital adrenal hyperplasia

    Hypercalcernia connected with cancer

    Nonsuppurative thyroiditis

  • Rheumatic Disorders

    As adjunctive therapy for short-term administration
      (to tide the individual over a critical episode or exacerbation) in:

    Psoriatic arthritis

    Rheumatoid arthritis symptoms, including juvenile rheumatoid arthritis
      (selected cases might require low-dose maintenance
      therapy)

    Ankylosing spondylitis

    Acute and subacute bursitis

    Acute nonspecific tenosynovitis

    Acute gouty arthritis

    Post-traumatic osteoarthritis

    Synovitis of osteoarthritis

    Epicondylitis

  • Collagen Diseases

    During an exacerbation or as maintenance therapy in selected
      cases of:

    Systemic lupus erythematosus

    Systemic-dermatomyositis (polymyositis)

    Acute rheumatic carditis

  • Dermatologic Diseases

    Pemphigus

    Bullous dermatitis herpetiformis

    Severe erythema multiforme

      (Stevens-Johnson syndrome)

    Exfoliative dermatitis

    Mycosis fungoides

    Severe psoriasis

    Severe seborrheic dermatitis

  • Allergic States

    Management of severe or incapacitating allergic conditions
      intractable to adequate trials of conventional treatment:

    Seasonal or perennial allergic rhinitis

    Bronchial asthma

    Contact dermatitis

    Atopic dermatitis

    Serum sickness

    Drug hypersensitivity reactions

  • Ophthalmic Diseases

    Severe acute and chronic allergic and inflammatory processes
      involving the eye as well as its adnexa for instance:

    Allergic cornea marginal ulcers

    Herpes zoster ophthalmicus

    Anterior segment inflammation

    Diffuse posterior uveitis and choroiditis

    Sympathetic ophthalmia

    Allergic conjunctivitis

    Keratitis

    Chorioretinitis

    Optic neuritis

    Iritis and iridocyclitis

  • Respiratory Diseases

    Symptomatic sarcoidosis

    Loeffler's syndrome not manageable by other means

    Berylliosis

    Fulminating or disseminated pulmonary tuberculosis when used
      concurrently with appropriate antituberculous chemotherapy

    Aspiration pneumonitis

  • Hematologic Disorders

    Idiopathic thrombocytopenic purpura in adults

    Secondary thrombocytopenia in adults

    Acquired (autoimmune) hemolytic anemia

    Erythroblastopenia (RBC anemia)

    Congenital (erythroid) hypoplastic anemia

  • Neoplastic Diseases
    For palliative control over:

    Leukemias and lymphomas in adults

    Acute leukemia of childhood

  • Edematous States

    To induce a diuresis or remission of proteinuria in the
      nephrotic syndrome, without uremia, from the idiopathic type
      or that as a result of lupus erythematosus

  • Gastrointestinal Diseases

    To tide the individual over the critical amount of the ailment in:
    Ulcerative colitis

    Regional enteritis

  • Nervous System

    Acute exacerbations of multiple sclerosis

  • Miscellaneous

    Tuberculous meningitis with subarachnoid block or impending
      block when used concurrently with appropriate antituberculous chemotherapy

    Trichinosis with neurologic or myocardial involvement


    Top of page


    CONTRAINDICATIONS


    Systemic fungal infections and known hypersensitivity to components.


    The surface of page


    WARNINGS


    In patients on corticosteroid therapy exposed to unusual stress, increased dosage of rapidly acting
    corticosteroids before, during, and following stressful situation is indicated.

    Corticosteroids may mask some warning signs of infection, and new infections may seem throughout their use. Infections
    with any pathogen including viral, bacterial, fungal, protozoan or helminthic infections, in every location from the
    body, can be from the by using corticosteroids alone or even in conjunction with other immunosuppressive
    agents that affect cellular immunity, humoral immunity, or neutrophil function. 1

    These infections could possibly be mild, but could be severe and also at times fatal. With increasing doses of corticosteroids, the
    rate of occurrence of infectious complications increases. 2 There can be decreased resistance and wherewithal to localize infection when corticosteroids are utilized. Prolonged by using corticosteroids may produce posterior subcapsular cataracts, glaucoma with possible problems for the optic nerves, and may improve the establishment of secondary ocular infections on account of fungi or viruses.


    Usage while being pregnant: Since adequate human reproduction numerous studies have not been through with corticosteroids, the
    utilization of these drugs in pregnancy, nursing mothers or women of childbearing potential necessitates that the potential
    benefits associated with the drug be weighed contrary to the potential hazards for the mother and embryo or fetus. Infants born of
    mothers who may have received substantial doses of corticosteroids when pregnant, should be carefully observed
    for signs of hypoadrenalism.

    Average and huge doses of hydrocortisone or cortisone could potentially cause elevation of high blood pressure, salt and water
    retention, and increased excretion of potassium. These effects are not as likely that occur with the synthetic
    derivatives except when utilised in, large doses. Dietary salt restriction and potassium supplementation might be
    necessary. All corticosteroids Increase calcium excretion.

    Administration of live or live, attenuated vaccines is contraindicated in patients receiving immunosuppressive
    doses of corticosteroids. Killed or inactivated vaccines could be administered to patients receiving
    immunosuppressive doses of corticosteroids; however, the reply to such vaccines might be diminished. Indicated immunization procedures might be undertaken in patients receiving nonimmunosuppressive doses of
    corticosteroids.

    Using DELTASONE Tablets in active tuberculosis really should be limited to those cases of fulminating or
    disseminated tuberculosis the location where the corticosteroid is employed with the therapy for the ailment in conjunction
    through an appropriate anti-tuberculous regimen.

    If corticosteroids are suggested for patients with latent tuberculosis or tuberculin reactivity, close observation is
    necessary as reactivation from the disease may occur. During prolonged corticosteroid therapy, these patients
    should receive chemoprophylaxis.

    Persons that are on drugs which suppress the defense mechanisms will be more susceptible to infections than healthy
    individuals. Chicken pox and measles, for instance, could have a rather more serious or maybe fatal course in non-immune
    children or adults on corticosteroids. In such children or adults that have not had these diseases, particular care
    really should be come to avoid exposure. How the dose, route and amount of corticosteroid administration affects the
    likelihood of setting up a disseminated infection is just not known. The contribution of the underlying disease and/or prior
    corticosteroid treatment to the risk is usually unfamiliar. If confronted with chicken pox, prophylaxis with varicella
    zoster immune globulin (VZIG) can be indicated. If exposed to measles, prophylaxis with pooled intramuscular
    immunoglobulin (IG) might be indicated. (Start to see the respective package inserts for complete VZIG and IG
    prescribing information. ) If chicken pox develops, treatment with antiviral agents can be considered. Similarly,
    corticosteroids. really should be in combination with great care in patients with known or suspected Strongyloides (threadworm)
    infestation. In such patients, corticosteroid-induced immunosuppression may cause Strongyloides
    hyperinfection and dissemination with widespread larval migration, often associated with severe enterocolitis
    and life-threatening gram-negative septicemia.


    The surface of page


    PRECAUTIONS


    General Precautions

    Drug-induced secondary adrenocortical insufficiency could be minimized by gradual lowering of dosage. This
    type of relative insufficiency may persist for months after discontinuation of therapy; therefore, in a situation of
    stress occurring in that period, hormone therapy really should be reinstituted. Since mineralocorticoid secretion
    may be impaired, salt and/or a mineralocorticoid should, be administered concurrently.

    We have an enhanced effect of corticosteroids on patients with hypothyroidism and in those with cirrhosis.

    Corticosteroids needs to be used cautiously in patients with ocular herpes simplex as a result of possible cornmeal
    perforation.

    The minimum possible dose of corticosteroid should be utilized to control the trouble under treatment, and when
    decline in dosage can be done, the reduction must be gradual.

    Psychic derangements can happen when corticosteroids are utilized, between euphoria, insomnia, mood
    swings, personality changes, and severe depression, to frank psychotic manifestations. coreg online without a prescription Also, existing emotional
    instability or psychotic tendencies could be aggravated by corticosteroids.

    Steroids really should be used in combination with caution in nonspecific ulcerative colitis, when there is a chance of impending
    perforation, abscess or any other pyogenic infection; diverticulitis; fresh intestinal anastomoses; active or latent peptic
    ulcer; renal insufficiency; hypertension; osteoporosis; and myasthenia gravis.

    Advancement of youngsters on prolonged corticosteroid therapy should be carefully
    observed.

    Kaposi's sarcoma has been reported to happen in patients receiving corticosteroid therapy. Discontinuation of
    corticosteroids may lead to clinical remission.

    Although controlled clinical trials demonstrate corticosteroids in order to work in speeding the resolution of acute
    exacerbations of multiple sclerosis, they just don't show corticosteroids affect the ultimate outcome or natural
    reputation of the sickness. The studies do demonstrate that relatively high doses of corticosteroids are needed to
    demonstrate a substantial effect. (See DOSAGE AND ADMINISTRATION. )

    Since complications of treatment with glucocorticoids are dependent upon how big the dose plus the duration of
    treatment, a risk/benefit decision should be created in each one case about dose and length of treatment and
    as to whether daily or intermittent therapy ought to be used.

    Convulsions have been reported with concurrent utilization of methylprednisolone and cyclosporin. Since concurrent
    use of these agents makes a mutual inhibition of metabolism, it will be possible that adverse events related to
    the average person utilization of either drug could possibly be more prone to occur.


    Drug Interactions

    The pharmacokinetic interactions here i will discuss potentially clinically important. Drugs that induce hepatic
    enzymes for example phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may
    require increases in corticosteroid dose to own desired response. Drugs like troleandomycin and
    ketoconazole may inhibit the metabolism of corticosteroids and so decrease their clearance. Therefore, the
    dose of corticosteroid should be titrated to protect yourself from steroid toxicity. Corticosteroids might increase the clearance of
    chronic high dose aspirin. This may lead to decreased salicylate serum levels or increase the risk of salicylate
    toxicity when corticosteroid is withdrawn. Aspirin really should be used cautiously in conjunction with corticosteroids
    in patients struggling with hypoprothrombinemia. The effect of corticosteroids on oral anticoagulants is variable. You can find reports of enhanced together with diminished results of anticoagulants when given concurrently with
    corticosteroids.

    Therefore, coagulation indices really should be monitored to keep up the required anticoagulant effect.


    Information for your Patient

    Persons who will be on immunosuppressant doses of corticosteroids should be warned to stop experience of
    chicken pox or measles. Patients ought to be advised when they are exposed, medical advice really should be
    sought at once.


    Top of page


    ADVERSE REACTIONS


    Fluid and Electrolyte Disturbances


      Sodium retention

      Fluid retention

      Congestive heart failure in susceptible patients

      Potassium loss

      Hypokalemic alkalosis

      Hypertension

    Musculoskeletal

      Muscle weakness

      Steroid myopathy

      Lack of muscle mass

      Osteoporosis

      Tendon rupture, particularly of the Achilles tendon

      Vertebral compression fractures

      Aseptic necrosis of femoral and humeral heads

      Pathologic fracture of long bones

    Gastrointestinal

      Peptic ulcer with possible perforation and hemorrhage
      Pancreatitis

      Abdominal distention

      Ulcerative esophagitis

      Increases in alanine transaminase (ALT, SGPT), aspartate
        transaminase (AST, SGOT) and alkaline phosphatase
        have been observed following corticosteroid treatment. These changes are often small, not associated with any
        clinical syndrome and therefore are reversible upon discontinuation.

    Dermatologic

      Impaired wound healing

      Thin fragile skin

      Petechiae and ecchymoses

      Facial erythema

      Increased sweating

      May suppress reactions to skin tests

    Metabolic

      Negative nitrogen balance due to protein catabolism

      Neurological

      Increased intracranial pressure with papilledema

        (pseudo-tumor cerebri) usually after treatment

      Convulsions

      Vertigo

      Headache

    Endocrine

      Menstrual irregularities

      Growth and development of Cushingoid state

      Secondary adrenocortical and pituitary unresponsiveness,
        specifically in times during the stress, as with trauma, surgical procedures or
        illness

      Suppression of rise in children

      Decreased carbohydrate tolerance

      Manifestations of latent diabetes mellitus

      Increased requirements for insulin or oral hypoglycemic agents
        in diabetics

    Ophthalmic

      Posterior subcapsular cataracts

      Increased intraocular pressure

      Glaucoma

      Exophthalmos

    Additional Reactions

      Urticaria and also other allergic, anaphylactic or hypersensitivity
        reactions


    Surface of page


    DOSAGE AND ADMINISTRATION


    Your initial dosage of DELTASONE Tablets can vary greatly from 5 mg to 60 mg of prednisone every day determined by
    the precise disease entity being managed. In situations of less severity lower doses will normally suffice while in
    selected patients higher initial doses are usually necesary. The initial dosage ought to be maintained or adjusted until a
    satisfactory fact is noted. If after the reasonable length of time you will find there's insufficient satisfactory clinical response,
    DELTASONE should be discontinued plus the patient moved to other appropriate therapy. It needs to
    BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE
    INDIVIDUALIZED Based on THE DISEASE UNDER TREATMENT Plus the RESPONSE OF THE PATIENT. After an encouraging solution is noted, the appropriate maintenance dosage should
    count on reducing the initial drug dosage in small decrements at appropriate time intervals till the
    lowest dosage that may maintain a satisfactory clinical response is reached. It really should be kept in mind that
    constant monitoring is necessary regarding drug dosage. Included inside situations which can make dosage
    adjustments necessary are changes in clinical status secondary to remissions or exacerbations inside the disease
    process, the patient's individual drug responsiveness, and the effect of patient contact stressful situations not
    directly related for the disease entity under treatment; on this latter situation it might be required to raise the
    dosage of DELTASONE for any length of time similar to the patient's condition. If after long-term therapy
    the drug is for being stopped, our recommendation is that it's withdrawn gradually rather than abruptly.


    Multiple Sclerosis

    Within the treatments for acute exacerbations of multiple sclerosis daily doses of 200 mg of prednisolone for just a week
    as well as 80 mg alternate day for 1 month have been shown succeed. (Dosage range is the similar for
    prednisone and prednisolone. )


    ADT (Alternate Day Therapy)


    ADT is usually a corticosteroid dosing regimen in which twice the most common daily dose of corticoid is administered every
    other morning. The reason for this mode of care is to supply the individual requiring long-term pharmacologic
    dose treatment together with the benefits of corticoids while minimizing certain undesirable effects, including
    pituitary-adrenal suppression, the Cushingoid state, corticoid withdrawal symptoms, and growth suppression in
    children.

    The explanation due to this treatment schedule is founded on two major premises: (a) the anti-inflammatory or
    therapeutic effect of corticoids persists over their physical presence and metabolic effects and (b)
    administration from the corticosteroid almost every other morning makes for re-establishment more nearly normal
    hypothalamic-pituitary-adrenal (HPA) activity around the off-steroid day.

    A quick article on the HPA physiology could possibly be useful understanding this rationale. Acting primarily through
    the hypothalamus an autumn in free cortisol stimulates the pituitary gland to make increasing quantities of
    corticotropin (ACTH) while an expansion in free cortisol inhibits ACTH secretion. Normally the HPA system is
    seen as a diurnal (circadian) rhythm. Serum levels of ACTH rise at a low point about 10 pm to your peak
    level about 6 am. Increasing degrees of ACTH stimulate adrenocortical activity resulting in a increase in plasma
    cortisol with maximal levels occurring between 2 am and 8 am. This increase in cortisol dampens ACTH production
    and as a consequence adrenocortical activity. There is a gradual fall in plasma corticoids in daytime with lowest levels
    occurring abmidnight.

    The diurnal rhythm with the HPA axis is lost in Cushing's disease, a syndrome of adrenocortical hyperfunction
    seen as obesity with centripetal fat distribution, thinning of the epidermis with easy bruisability, muscle
    wasting with weakness, hypertension, latent diabetes, osteoporosis, electrolyte imbalance, etc. The same clinical
    findings of hyperadrenocorticism can be noted during long-term pharmacologic dose corticoid therapy
    administered in conventional daily-divided doses. It seems, then, a disturbance from the diurnal cycle
    with upkeep of elevated corticoid values when asleep may play a tremendous role inside development of
    undesirable corticoid effects. Escape from these constantly elevated plasma levels even for short intervals
    might be instrumental in protecting against undesirable pharmacologic effects.

    During conventional pharmacologic dose corticosteroid therapy, ACTH production is inhibited with subsequent
    suppression of cortisol production with the adrenal cortex. Recovery time for normal HPA activity is variable
    based upon the dose and length of treatment. During these times the individual is liable to any stressful
    situation. Although it's been shown there's much less adrenal suppression carrying out a single
    morning dose of prednisolone (10 mg) rather than a quarter of that dose administered every 6 hours, there may be
    evidence that some suppressive influence on adrenal activity may be carried over into the following day when
    pharmacologic doses are being used. Further, many experts have shown a single dose of certain corticosteroids will
    produce adrenocortical suppression for just two if not more days. Other corticoids, including rnethylprednisolone,
    hydrocortisone, pednisone and prednisolone, are viewed as to become short acting (producing adrenocortical
    suppression for 1 1/4 to at least one 1/2 days carrying out a single dose) and therefore are recommended for alternate day therapy.

    This must be kept in mind when it comes to alternate day therapy:

  • Fundamental principles and indications for corticosteroid therapy should apply. The important things about ADT shouldn't
    encourage the indiscriminate use of steroids.
  • ADT is often a therapeutic technique primarily designed for patients in whom long-term pharmacologic corticoid
    treatment therapy is anticipated.
  • In less severe disease processes by which corticoid care is indicated, it can be possible to initiate
    treatment with ADT. More severe disease states usually requires daily divided high dose therapy for initial
    power over the ailment process. The initial suppressive dose level must be continued until satisfactory clinical
    response is obtained, usually four to 10 days in the case of many allergic and collagen diseases. It is significant
    to hold the period of initial suppressive dose as brief as it can be especially when subsequent by using alternate
    day therapy is intended.

    Once control continues to be established, two is available: (a) switch to ADT and after that gradually reduce the
    number of corticoid given every other day or (b) following management of the illness process reduce the daily dose of
    corticoid towards the lowest effective level as rapidly as is possible then change to the site another day schedule. Theoretically, course (a) could possibly be preferable.

  • Due to advantages of ADT, it could be desirable to try patients within this sort of therapy who are
    on daily corticoids for long periods of time (eg, patients with rheumatoid arthritis symptoms symptoms). Since these patients may
    already have a suppressed HPA axis, establishing them on ADT may be difficult rather than always successful. However, it is recommended that regular attempts be generated to switch them over. It might be helpful to triple or
    even quadruple the daily maintenance dose and administer this alternate day as an alternative to just doubling the daily
    dose if difficulty is encountered. Once the sufferer is again controlled, an effort ought to be meant to reduce this
    dose low.

  • As indicated above, certain corticosteroids, for their prolonged suppressive affect on adrenal activity,
    will not be appropriate for alternate day therapy (eg, dexamethasone and betamethasone).

  • The maximal activity of the adrenal cortex is between 2 am and 8 am, and it's minimal between 4 pm and
    midnight. Exogenous corticosteroids suppress adrenocortical activity the smallest amount of, when given before
    maximal activity (am).
  • In employing ADT it is crucial, such as all therapeutic situations to individualize and tailor the treatment to each and every
    patient. Complete control of symptoms are not possible in all patients. An explanation on the benefits associated with
    ADT can help the patient to be aware of and tolerate the potential flare-up in symptoms which might occur in the
    latter area of the off-steroid day. Other symptomatic therapy can be added or increased at the moment when necessary.
  • In case of a critical flare-up on the disease process, it can be important to resume an entire suppressive
    daily divided corticoid dose for control. Once control is again established alternate day therapy could possibly be re-
    instituted.
  • Although some in the undesirable popular features of corticosteroid therapy may be minimized by ADT, such as any
    therapeutic situation, the physician must carefully weigh the benefit-risk ratio for each patient in whom corticoid
    remedies are being considered.


    Surface of page


    HOW SUPPLIED


    DELTASONE Tablets come in the subsequent strengths and package sizes:
    2. 5 mg (pink, round, scored, imprinted DELTASONE 2. 5)
    Bottles of 100NDC 0009-0032-01
    5 mg (white, round, scored, imprinted DELTASONE 5)
    Bottles of 100NDC 0009-0045-01
    Bottles of 500NDC 0009-0045-02
    Bottles of 1000NDC 0009-0045-16
    DOSEPAK Unit-of-Use (21 tablets)
    NDC 0009-0045-04
    Unit Dose Packages (100)NDC 0009-0045-05
    10 mg (white, round, scored, imprinted DELTASONE 10)
    Bottles of 100NDC 0009-0193-01
    Bottles of 500NDC 0009-0193-02
    Unit Dose Packages (100)NDC 0009-0193-03
    20 mg (peach, round, scored, imprinted DELTASONE 20)
    Bottles of 100NDC 0009-0165-01
    Bottles of 500 NDC 0009-0165-02
    Unit Dose Packages (100) NDC 0009-0165-03
    50 mg (white, round, scored, imprinted DELTASONE 50)
    Bottles of 100 NDC 0009-0388-01
    Store at controlled room temperature 15 to 30C (59 to 86 F).


    REFERENCES

    1 Fekety R. Infections linked to corticosteroids and immunosuppressive therapy. In: Gorbach SL,
    Bartlett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia: WBSaunders Company 1992:1050-1.


    2 Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticoids. Rev
    Infect Dis 1989:11(6):954-63.


    Caution: Federal law prohibits dispensing without prescription.


    The Upjohn Company
    Kalamazoo, MI 49001, USA


    Revised September 1995

    810 342 017

    691015










    .



  • (Post a new comment)



    Home | Site Map | Manage Account | TOS | Privacy | Support | FAQs